Jimin Health (603222.SH) announced that its wholly-owned subsidiary, Jumin Biotechnology Co., Ltd. (referred to as "...")
According to Zhitong Finance APP, Jimin Health (603222.SH) announced that its wholly-owned subsidiary, Jumin Biotechnology Co., Ltd. (referred to as "Jumin Biotechnology") recently signed a "Manufacturing Agreement" with Retractable Technologies, Inc. (referred to as "RTI") in the USA for the contract manufacturing of products including safety injection needles and safety syringes.
